{"blog": [], "keywords": [{"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Pearson, John Michael (1959- )", "name": "persons", "rank": "2", "is_major": "Y"}, {"value": "Ingram, Robert A", "name": "persons", "rank": "3", "is_major": "N"}, {"value": "Schiller, Howard B", "name": "persons", "rank": "4", "is_major": "N"}, {"value": "Appointments and Executive Changes", "name": "subject", "rank": "5", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/02/29/business/valeant-pharmaceuticals-j-michael-pearson-ceo.html", "document_type": "article", "byline": {"person": [{"lastname": "POLLACK", "firstname": "Andrew", "role": "reported", "organization": "", "rank": 1}], "original": "By ANDREW POLLACK"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/02/29/business/29valeant-web/29valeant-web-thumbWide.jpg", "legacy": {"wide": "images/2016/02/29/business/29valeant-web/29valeant-web-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/02/29/business/29valeant-web/29valeant-web-articleLarge.jpg", "legacy": {"xlarge": "images/2016/02/29/business/29valeant-web/29valeant-web-articleLarge.jpg", "xlargeheight": "395", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 395}, {"url": "images/2016/02/29/business/29valeant-web/29valeant-web-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/02/29/business/29valeant-web/29valeant-web-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "686", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "J. Michael Pearson is returning as chief executive after two months, but is giving up his role as chairman.", "pub_date": "2016-02-29T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "<span data-tag=\"loosen__9\">Valeant Chief Returns After Medical Leave</span>", "main": "Valeant Pharmaceuticals Chief Returns From Medical Leave"}, "print_page": "7", "snippet": "J. Michael Pearson is returning as chief executive after two months, but is giving up his role as chairman.", "_id": "56d39e2438f0d86ef22e17b7", "slideshow_credits": null, "abstract": "J Michael Pearson returns as chief executive of Valeant Pharmaceuticals after two months of medical leave; says he will restore investor confidence in beleaguered company."}